Article
Novel lipid emulsion for total parenteral nutrition based on 18-carbon n-3 fatty acids elicits a superior immunometabolic phenotype in a murine model compared with standard lipid emulsions.
The American journal of clinical nutrition - 19 Dec 2022
Lucchinetti Eliana, Lou Phing-How, Holtzhauer Gregory, Noureddine Nazek, Wawrzyniak Paulina, Hartling Ivan, Lee Megan, Strachan Erin, Clemente-Casares Xavier, Tsai Sue, Rogler Gerhard, Krämer Stefanie D, Hersberger Martin, Zaugg Michael
Abstract excerpt
BACKGROUND: While lipid emulsions in modern formulations for total parenteral nutrition (TPN) provide essential fatty acids and dense calories, they also promote inflammation and immunometabolic disruptions. OBJECTIVES: We aimed to develop a novel lipid emulsion for TPN use with superior immunometabolic actions compared with available standard lipid emulsions. METHODS: A novel lipid emulsion [Vegaven (VV)]...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
